Insights On Drug Discovery
-
Reduce Costly Scale-Up Problems
4/11/2024
Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.
-
Host Cell Impurities, Bioassays, Micro-Flow Imaging
4/9/2024
Ensuring the safety and efficacy of cutting-edge biopharmaceuticals hinges on meticulous quality control measures. Explore the role of qPCR and MFI in safeguarding drugs from potential contamination.
-
The Role Of Early Characterization Studies In The Assessment Of Advanced Therapeutic Potency
3/21/2024
Early product characterization can serve to uncover crucial information about an advanced therapeutic candidate, affording new insight into its CQAs and helping to shape better analytical assays.
-
The Write Side Of AI: Helping Hands, Not Replacement Plans
3/1/2024
AI applications in medical writing are in their infancy, and the technology suffers several shortcomings including plagiarism, copyright infringement, and misinformation dissemination.
-
Bacteria Media Optimization Using In Silico Strategies
2/21/2024
Determining ideal media composition for a bacteria is critical because it fosters a satisfactory grow rate, allowing the bacteria to reach the required growth yield.
-
The Process Of Developing Monoclonal Antibodies For Clinical Use
1/25/2024
Explore the potential of mAbs in treating diverse conditions, from cancer to infectious diseases, and learn about their transformation from scientific breakthroughs to life-changing therapies.
-
Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials
1/24/2024
Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.
-
Leveraging Stable Pool Material To Expedite The Path To IND
1/10/2024
Review the efficacy of fast stable pools in generating purified product at an early stage and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.
-
Clear MRSA Infections At Single Low Doses
1/4/2024
Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.
-
The MAPPs Assay: A Useful Tool For The Assessment Of Immunogenicity
1/4/2024
Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.